Integrated Wealth Management (Palm Desert)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-347
Closed -$109K 313
2016
Q3
$109K Sell
347
-97
-22% -$28.7K 0.04% 308
2016
Q2
$107K Hold
444
0.04% 304
2016
Q1
$116K Buy
444
+106
+31% +$28K 0.05% 263
2015
Q4
$104K Hold
338
0.04% 272
2015
Q3
$99K Sell
338
-6
-2% -$1.98K 0.04% 268
2015
Q2
$139K Buy
344
+92
+37% +$36.9K 0.05% 238
2015
Q1
$106K Buy
+252
New +$99.3K 0.04% 264

Other funds holding BIIB

Integrated Wealth Management (Palm Desert)'s BIIB Position: Q4 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of Biogen (BIIB) in Q4 2016, closing a stake of 347 shares — an estimated $109K sold.

Integrated Wealth Management (Palm Desert) first reported a position in BIIB in Q1 2015 and held it in 7 quarters. The position peaked at $139K in Q2 2015. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • Integrated Wealth Management (Palm Desert) reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
  • Integrated Wealth Management (Palm Desert) sold 347 Biogen shares in Q4 2016, an estimated $109K.
  • Integrated Wealth Management (Palm Desert) first reported a position in Biogen in Q1 2015 and held it in 7 quarters.
  • Integrated Wealth Management (Palm Desert)'s Biogen position peaked at $139K in Q2 2015.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q4 2016, filed 6 Jan 2017.